Biotech

All Articles

ArsenalBio raises $325M, turns away from former lead property

.Arsenal Biosciences is actually proceeding up. The tissue treatment firm has actually added $325 mi...

Lilly- supported weight-loss biotech files IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' cannabis usage medicine fails stage 2b, steering Indivior to reassess $100M alternative

.Aelis Farma's chances of securing a simple, positive choice on a $one hundred thousand possibility ...

ProKidney halts period 3 test certainly not required for tissue therapy authorization

.ProKidney has actually ceased among a set of stage 3 tests for its own cell treatment for kidney he...

Vaxcyte climbs on 'sensational' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what experts referred to as "impressive" period 1/2 records for its own 31-valent ...

Recursion's mind ailment test reveals insufficient documentation of effectiveness

.Recursion has stumbled by means of an early test of its own tech-enabled strategy to drug explorati...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Call it a scenario of excellent chemical make up: Acepodia, a biotech based on Nobel Champion scien...

Praxis epilepsy medication lowers confiscations in phase 2 trial

.Practice Preciseness Medicines has actually racked up one more midphase succeed in epilepsy this ye...

Three officers surrender as Dyne messages mixed data for DMD prospect

.After getting away a medical grip numerous years back, Dyne Therapy has uncovered brand-new phase 1...

Arrowhead fires off phase 3 information in rare metabolic ailment ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its give in advance of a possible showdown along with Ionis,...